Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 3,837 TARS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 3,837 | n/a |
| Jun 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 2,954 | $183.4K |
| Jun 16, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,954 | n/a |
| Jan 15, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,233 | n/a |
| Jun 16, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 4,540 | n/a |
| Nov 15, 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 10,000 | n/a |